重症肌无力治疗方面的争议。
Controversies about the treatment of myasthenia gravis.
作者信息
Rowland L P
出版信息
J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):644-59. doi: 10.1136/jnnp.43.7.644.
Abstract
Clinicians treating patients with myasthenia gravis must choose cholinergic drugs, corticosteroids, immunosuppressive drugs, thymectomy, or plasmapheresis. Clinicians must decide the sequence or combination of these therapies and when to deem lack of improvement a sign for a different therapeutic approach. Because controlled trials have not been done to evaluate therapies that may require months or years before benefit is evident, controversy abounds.
摘要
治疗重症肌无力患者的临床医生必须选择胆碱能药物、皮质类固醇、免疫抑制药物、胸腺切除术或血浆置换。临床医生必须决定这些治疗方法的顺序或组合，以及何时将缺乏改善视为采用不同治疗方法的指征。由于尚未进行对照试验来评估可能需要数月或数年才能显效的治疗方法，因此争议颇多。
相似文献
1
Controversies about the treatment of myasthenia gravis.重症肌无力治疗方面的争议。
J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):644-59. doi: 10.1136/jnnp.43.7.644.
2
Management of myasthenia gravis.重症肌无力的管理
Semin Neurol. 2004 Mar;24(1):41-8. doi: 10.1055/s-2004-829586.
3
Therapeutic options in autoimmune myasthenia gravis.自身免疫性重症肌无力的治疗选择
Autoimmun Rev. 2007 Jun;6(6):373-8. doi: 10.1016/j.autrev.2007.01.001. Epub 2007 Jan 30.
4
[Myasthenia gravis: critical evaluation of the treatment].[重症肌无力：治疗的批判性评估]
Arq Neuropsiquiatr. 1990 Mar;48(1):55-70. doi: 10.1590/s0004-282x1990000100009.
5
[Treatment of juvenile myasthenia gravis].[青少年重症肌无力的治疗]
Medicina (B Aires). 2019;79 Suppl 3:71-76.
6
[Therapeutic considerations in myasthenia gravis].[重症肌无力的治疗考量]
Cesk Neurol Neurochir. 1984 Mar;47(2):78-84.
7
[Myasthenia gravis. Treatment].[重症肌无力。治疗]
Ugeskr Laeger. 1984 Jan 30;146(5):345-8.
8
The treatment of patients with myasthenia gravis.重症肌无力患者的治疗。
Neurol Clin. 1994 May;12(2):343-68.
9
Myasthenia gravis: clinical, immunological, and therapeutic advances.重症肌无力：临床、免疫学及治疗进展
Acta Neurol Scand. 2005 Feb;111(2):134-41. doi: 10.1111/j.1600-0404.2005.00374.x.
10
[Myasthenia gravis. Recent findings and their therapeutic consequences].[重症肌无力。最新研究发现及其治疗意义]
Dtsch Med Wochenschr. 1979 Oct 5;104(40):1415-20. doi: 10.1055/s-0028-1129112.
引用本文的文献
1
Surgical innovation, statistical analysis, and professional culture: thymectomy for myasthenia gravis, 1936-2016.外科创新、统计分析与专业文化：1936年至2016年重症肌无力的胸腺切除术
Med Hist. 2025 Jan;69(1):166-182. doi: 10.1017/mdh.2024.35. Epub 2025 Apr 7.
2
History of Myasthenia Gravis Revisited.重症肌无力病史再探。
Noro Psikiyatr Ars. 2020 Nov 7;58(2):154-162. doi: 10.29399/npa.27315. eCollection 2021 Jun.
3
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.糖皮质激素治疗后重症肌无力恶化：有何证据？系统评价。
J Neurol. 2021 Dec;268(12):4573-4586. doi: 10.1007/s00415-020-10264-0. Epub 2020 Oct 16.
4
Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan.日本一项多中心横断面研究：全身性重症肌无力的口服皮质类固醇剂量方案与长期预后。
J Neurol Neurosurg Psychiatry. 2018 May;89(5):513-517. doi: 10.1136/jnnp-2017-316625. Epub 2017 Nov 24.
5
Acetylcholinesterase inhibitor treatment for myasthenia gravis.重症肌无力的乙酰胆碱酯酶抑制剂治疗
Cochrane Database Syst Rev. 2014 Oct 13;2014(10):CD006986. doi: 10.1002/14651858.CD006986.pub3.
6
Myasthenia gravis: past, present, and future.重症肌无力：过去、现在与未来。
J Clin Invest. 2006 Nov;116(11):2843-54. doi: 10.1172/JCI29894.
7
Thymectomy for myasthenia gravis.重症肌无力的胸腺切除术
Postgrad Med J. 1998 Mar;74(869):139-44. doi: 10.1136/pgmj.74.869.139.
8
Ocular myasthenia gravis: response to long-term immunosuppressive treatment.眼肌型重症肌无力：长期免疫抑制治疗的反应
J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):156-62. doi: 10.1136/jnnp.62.2.156.
9
A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group.一项比较泼尼松和硫唑嘌呤治疗重症肌无力的随机临床试验。第二次中期分析结果。重症肌无力临床研究组。
J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1157-63. doi: 10.1136/jnnp.56.11.1157.
10
Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.眼肌型重症肌无力。临床与病理生理学方面的批判性综述。
Doc Ophthalmol. 1993;84(4):309-33. doi: 10.1007/BF01215447.
本文引用的文献
1
EFFECTS OF ADRENOCORTICOTROPHIC HORMONE ON NEURO-MUSCULAR FUNCTION IN PATIENTS WITH MYASTHENIA GRAVIS.促肾上腺皮质激素对重症肌无力患者神经肌肉功能的影响
J Clin Invest. 1949 Sep;28(5 Pt 2):1228-35. doi: 10.1172/JCI102157.
2
Corticotropin and cortisone in diseases of the nervous system.促肾上腺皮质激素和可的松在神经系统疾病中的应用
Yale J Biol Med. 1952 Jun;24(6):466-73.
3
4
Effects of corticotropin (ACTH) and cortisone on disorders of the nervous system.促肾上腺皮质激素（ACTH）和可的松对神经系统疾病的影响。
J Am Med Assoc. 1952 Mar 15;148(11):898-904. doi: 10.1001/jama.1952.02930110020006.
5
Present status of therapy in myasthenia gravis.重症肌无力的治疗现状
J Am Med Assoc. 1952 Feb 16;148(7):508-13. doi: 10.1001/jama.1952.02930070008003.
6
Effects of administration of the adrenocorticotropic hormone on patients with myasthenia gravis.促肾上腺皮质激素给药对重症肌无力患者的影响。
AMA Arch Neurol Psychiatry. 1951 Aug;66(2):163-70. doi: 10.1001/archneurpsyc.1951.02320080047004.
7
Clinical-evaluation of ACTH and cortisone in myasthenia gravis.促肾上腺皮质激素和可的松在重症肌无力中的临床评估
Neurology. 1951 Mar-Apr;1(2):145-52. doi: 10.1212/wnl.1.3.145.
8
Investigations into thymic disease and tumour formation.胸腺疾病与肿瘤形成的研究。
Br J Surg. 1955 Mar;42(175):449-62. doi: 10.1002/bjs.18004217502.
9
CORTICOTROPIN IN TREATMENT OF OCULAR MYASTHENIA; A CONTROLLED CLINICAL TRIAL.促肾上腺皮质激素治疗眼肌型重症肌无力；一项对照临床试验。
Arch Neurol. 1964 Aug;11:114-24. doi: 10.1001/archneur.1964.00460200010002.
10
Diagnosis and treatment of myasthenia gravis in infancy, childhood, and adolescence: a study of 51 patients.婴幼儿及青少年重症肌无力的诊断与治疗：51例患者的研究
Neurology. 1960 Nov;10:1007-14. doi: 10.1212/wnl.10.11.1007.
Zotero 插件